New Therapy for Heart Failure Shows Early Benefit

Armen Hareyan's picture

Heart Failure

The trial of a new drug showed early benefit in reducing deaths and lowering an important heart disease marker in the sickest heart failure patients, though the study did not meet its overall ambitious goal to reduce death by 25 percent at six months, researchers reported today at a late-breaking clinical trials session at the American Heart Association's Scientific Sessions 2005.

Alexandre Mebazaa, M.D., Ph.D., a professor of Anesthesia and Critical Care Medicine at the H